ICD-10 Code D57.434 | Sickle-cell thalassemia beta zero with dactylitis Symptoms, Diagnosis, Billing

Sickle-cell thalassemia beta zero with dactylitis is a genetic blood disorder characterized by the presence of both sickle cell disease and beta-thalassemia. This condition leads to abnormal hemoglobin production, resulting in sickle-shaped red blood cells that can cause vaso-occlusive crises, pain, and dactylitis, which is swelling of the fingers and toes. Accurate coding with ICD-10 Code D57.434 is essential for proper diagnosis, documentation, medical billing, and public health reporting.

What is ICD-10 Code D57.434 for Sickle-cell thalassemia beta zero with dactylitis?

ICD-10 Code D57.434 specifically denotes Sickle-cell thalassemia beta zero with dactylitis, a condition resulting from the combination of sickle cell disease and beta-thalassemia. This code should be used in clinical documentation and billing when a patient presents with symptoms related to this specific genetic disorder, including pain crises and dactylitis.

ICD-10 Code D57.434 – Clinical Definition and Explanation of Sickle-cell thalassemia beta zero with dactylitis

Sickle-cell thalassemia beta zero with dactylitis is caused by mutations in the HBB gene, leading to the production of abnormal hemoglobin. This condition can result in severe complications, including pain episodes and increased risk of infections, necessitating medical attention.

Key Clinical Features:

• Presence of dactylitis, often seen in infants and young children.
• Recurrent pain crises due to vaso-occlusion.
• Increased susceptibility to infections.
• Anemia and fatigue due to hemolysis.

ICD-10 Code D57.434 for Sickle-cell thalassemia beta zero with dactylitis – SOAP Notes & Clinical Use

ICD-10 Code D57.434 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition.

What Does ICD-10 Code D57.434 for Sickle-cell thalassemia beta zero with dactylitis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D57.434 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis. This code supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D57.434 – Sickle-cell thalassemia beta zero with dactylitis

Management of Sickle-cell thalassemia beta zero with dactylitis requires a multifaceted approach to address symptoms and prevent complications.

Antibiotic Therapy:

• Penicillin prophylaxis for children until age 5.
• Ceftriaxone for acute infections.
• Alternative: Azithromycin for patients with penicillin allergy.

Supportive Care:

• Hydration and pain management during crises.
• Regular blood transfusions to manage anemia.
• Vaccinations to prevent infections.

Infection Control:

• Strict hand hygiene practices.
• Isolation precautions during acute infections.
• Education on recognizing signs of infection.

How to Document Symptoms of Sickle-cell thalassemia beta zero with dactylitis (ICD-10 D57.434) in SOAP Notes

Subjective:

• Patient reports recurrent pain in hands and feet.
• History of dactylitis episodes.
• Complaints of fatigue and weakness.
• Frequent hospital visits for pain management.

Objective:

• Swelling noted in fingers and toes.
• Anemia observed on complete blood count.
• Elevated bilirubin levels indicating hemolysis.
• Vital signs stable with occasional fever during crises.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Sickle-cell thalassemia beta zero with dactylitis (ICD-10 Code D57.434)

Assessment:

• Diagnosis: Sickle-cell thalassemia beta zero with dactylitis, moderate severity.
• ICD-10 subcode: D57.434.
• Triggers include dehydration and infection.
• Patient exhibits signs of vaso-occlusive crisis.

Plan:

• Administer pain relief medications as needed.
• Initiate hydration therapy.
• Schedule regular follow-up for blood transfusions.
• Educate patient on recognizing early signs of infection.

Treatment & Plan Section for ICD-10 Code D57.434 – Sickle-cell thalassemia beta zero with dactylitis

• First-line pharmacologic treatments include analgesics and hydration.
• Non-pharmacologic strategies involve patient education on crisis management.
• Monitoring includes regular CBC and bilirubin levels.
• Follow-up practices should include routine assessments for complications.

Using ICD-10 Code D57.434 for Sickle-cell thalassemia beta zero with dactylitis in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• List CPT codes that are commonly billed with ICD-10 Code D57.434.

Related ICD-10 Codes Often Used with Sickle-cell thalassemia beta zero with dactylitis

• D57.431 – Sickle-cell thalassemia beta plus with dactylitis
• D57.439 – Sickle-cell thalassemia beta unspecified with dactylitis

ICD-10 Code D57.434 in Medical Billing and Insurance for Sickle-cell thalassemia beta zero with dactylitis

ICD-10 Code D57.434 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and symptomatology.
• Use this code in conjunction with appropriate CPT codes for comprehensive billing.
• Highlight any complications or comorbidities in the medical record.

Common CPT Pairings: